Arrowhead’s Plozasiran Meets Key Goals in Phase 3...
Category : Clinical Trial Update 25 July 2026SHASTA-3 and SHASTA-4 show major triglyceride reductions and fewer acute pancreatitis events Arro...
Clinical Trial Update
LB Pharmaceuticals Moves Up LB-102 Schizophrenia T...
Category : Clinical Trial Update 24 July 2026Company accelerates topline results from pivotal NOVA-2 study LB Pharmaceuticals is bringing forw...
GSK's ViiV Healthcare to Present New HIV Treatment...
Category : Clinical Trial Update 22 July 2026Data will cover daily oral treatments, long-acting injectables and HIV prevention GSK plc announc...
Armata Pharmaceuticals Moves AP-SA02 Closer to Pha...
Category : Clinical Trial Update 21 July 2026Company submits Phase 3 protocol and FDA responses as it prepares for planned second-half 2026 trial...
Insmed Reports Positive 12-Month TPIP Data, Advanc...
Category : Clinical Trial Update 20 July 2026Insmed Incorporated has announced positive 12-month results from its ongoing open-label extension (O...
Latest Newsletter Post
-
Arrowhead’s Plozasiran Meets Key Go..
25 July 2026
-
Akums Drugs to Acquire Oriflame Ind..
25 July 2026
-
LB Pharmaceuticals Moves Up LB-102..
24 July 2026
-
Zydus Lifesciences Gets Approval fo..
24 July 2026
-
Ipsen Completes Acquisition of Memo..
24 July 2026
